{"id":20245,"date":"2026-02-04T11:43:20","date_gmt":"2026-02-04T11:43:20","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/se\/?page_id=20245"},"modified":"2026-02-04T11:45:48","modified_gmt":"2026-02-04T11:45:48","slug":"non-financial-information-statement","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/","title":{"rendered":"Non-Financial Information Statement"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"20245\" class=\"elementor elementor-20245\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3dc7da9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3dc7da9\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ca0391e\" data-id=\"ca0391e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5a2e075 elementor-widget elementor-widget-spacer\" data-id=\"5a2e075\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7084abb elementor-widget elementor-widget-text-editor\" data-id=\"7084abb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>(Non-Financial Information Statement &#8211; EINF in Spanish)<\/p><p>In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.) must prepare its Non-Financial Information Statement annually and comply with the recommendations and indications established by the aforementioned Law 11\/2018.<\/p><p>The report includes information on environmental, social and personal issues, human rights, the fight against corruption and bribery, and how the organisation affects society. For each of the issues, it describes the policies and actions that develop, as well as the risks identified and arising from the development of the company&#8217;s activity. The report has been prepared in accordance with the principles of comparability, reliability, materiality and relevance set out in the aforementioned Act 11\/2018.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-a424f8a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a424f8a\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-daafd6d\" data-id=\"daafd6d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-33358bf elementor-widget elementor-widget-button\" data-id=\"33358bf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2026\/02\/04114450\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Report 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-6727aa1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6727aa1\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-fc7a658\" data-id=\"fc7a658\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-35fde8b elementor-widget elementor-widget-button\" data-id=\"35fde8b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2026\/02\/04114456\/informe-einf-laboratorios-lesvi-2022.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Report 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7648f39 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7648f39\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-ddf1d83\" data-id=\"ddf1d83\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7ced1dd elementor-widget elementor-widget-button\" data-id=\"7ced1dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2026\/02\/04114503\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Report 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>(Non-Financial Information Statement &#8211; EINF in Spanish) In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.) must prepare its Non-Financial Information Statement annually and comply with the recommendations and indications established by the aforementioned Law 11\/2018. The report includes information on environmental, social and personal [&hellip;]<\/p>\n","protected":false},"author":2493,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"class_list":["post-20245","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Icke-finansiell information - Neuraxpharm SE<\/title>\n<meta name=\"description\" content=\"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Non-Financial Information Statement\" \/>\n<meta property=\"og:description\" content=\"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm SE\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-04T11:45:48+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/non-financial-information-statement\\\/\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/non-financial-information-statement\\\/\",\"name\":\"Icke-finansiell information - Neuraxpharm SE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/#website\"},\"datePublished\":\"2026-02-04T11:43:20+00:00\",\"dateModified\":\"2026-02-04T11:45:48+00:00\",\"description\":\"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/non-financial-information-statement\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/non-financial-information-statement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/non-financial-information-statement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Non-Financial Information Statement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/\",\"name\":\"Neuraxpharm SE\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Icke-finansiell information - Neuraxpharm SE","description":"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement","og_locale":"sv_SE","og_type":"article","og_title":"Non-Financial Information Statement","og_description":"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.","og_url":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/","og_site_name":"Neuraxpharm SE","article_modified_time":"2026-02-04T11:45:48+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/","url":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/","name":"Icke-finansiell information - Neuraxpharm SE","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/se\/#website"},"datePublished":"2026-02-04T11:43:20+00:00","dateModified":"2026-02-04T11:45:48+00:00","description":"L\u00e4s Neuraxpharms icke-finansiella rapport 2023. Uppt\u00e4ck hur vi arbetar med milj\u00f6, sociala fr\u00e5gor och m\u00e4nskliga r\u00e4ttigheter.","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/se\/non-financial-information-statement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/se\/"},{"@type":"ListItem","position":2,"name":"Non-Financial Information Statement"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/se\/#website","url":"https:\/\/www.neuraxpharm.com\/se\/","name":"Neuraxpharm SE","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/20245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/users\/2493"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/comments?post=20245"}],"version-history":[{"count":4,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/20245\/revisions"}],"predecessor-version":[{"id":20254,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/20245\/revisions\/20254"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/media?parent=20245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}